Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development
|
Canada's policy regarding the rules governing the legalization of marijuana
|
Policies or Program
|
|
Health, Justice and Law Enforcement, Taxation and Finance
|
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations.
|
Policies or Program, Legislative Proposal, Bill or Resolution, Regulation
|
|
Health, Justice and Law Enforcement
|
Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts.
Cannabis Act SC 2018 S16
|
Legislative Proposal, Bill or Resolution
|
|
Research and Development
|
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
|
Legislative Proposal, Bill or Resolution
|
|
Health
|
Regulations affiliated with Bill C- 45 regarding the legalization of cannabis.
Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts.
|
Regulation
|
Licensed producer of medical marijuana
Miguel Martin, CEO
Address:
409 Granville Street
Suite 1700
Vancouver, BC V6C 1T2
Canada
Telephone number:
437-992-8325
Aurora Cannabis Inc. is not a subsidiary of any other parent companies.
Please note that the significant part of duties threshold will change on January 19, 2026. Registrations with an effective date prior to this date will be subject to the current threshold (20% rule). For more information, please consult our interpretation bulletin.